Predictions
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€5.34
30.05.23
30.05.23
-
30.05.24
30.05.24
14.61%
24.07.23
24.07.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€1.14
08.12.22
08.12.22
€1.60
08.12.23
08.12.23
-59.94%
22.07.23
22.07.23
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.02
30.05.23
30.05.23
-
30.05.24
30.05.24
5.00%
17.07.23
17.07.23
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Endeavour Silver Corp.
Start price
Target price
Perf. (%)
€2.88
30.05.23
30.05.23
-
30.05.24
30.05.24
6.81%
17.07.23
17.07.23
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
EBIT growth > 30% per year expected
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€1.42
11.07.22
11.07.22
€1.00
11.07.23
11.07.23
-62.68%
12.07.23
12.07.23
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€0.83
11.01.23
11.01.23
€1.00
11.01.24
11.01.24
-37.36%
24.06.23
24.06.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Mandalay Resources Corp.
Start price
Target price
Perf. (%)
€1.16
19.06.23
19.06.23
-
19.06.24
19.06.24
2.94%
24.06.23
24.06.23
Could be very worthwhile Investment >20% year
Lithium Americas Corp.
Start price
Target price
Perf. (%)
€20.12
13.06.22
13.06.22
€28.00
13.06.23
13.06.23
-2.71%
14.06.23
14.06.23
Endeavour Silver Corp.
Start price
Target price
Perf. (%)
€3.77
11.06.22
11.06.22
€3.30
11.06.23
11.06.23
-23.61%
12.06.23
12.06.23
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Fair valuation
Lower EBIT Margin than peer group
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.60
16.04.23
16.04.23
-
16.04.24
16.04.24
-16.11%
30.05.23
30.05.23
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.22
11.03.23
11.03.23
€4.60
11.03.24
11.03.24
18.48%
19.05.23
19.05.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.87
24.03.23
24.03.23
-
24.03.24
24.03.24
12.58%
18.05.23
18.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.55
03.01.23
03.01.23
-
03.01.24
03.01.24
78.44%
14.05.23
14.05.23
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.86
27.10.21
27.10.21
€40.00
31.12.23
31.12.23
-59.32%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.45
18.10.21
18.10.21
€12.00
31.12.23
31.12.23
-2.68%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.49
10.10.21
10.10.21
€5.00
31.12.23
31.12.23
-32.83%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€1.17
23.10.22
23.10.22
€1.30
23.10.23
23.10.23
-48.66%
06.05.23
06.05.23
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.46
04.01.23
04.01.23
€12.00
31.12.25
31.12.25
63.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.23
28.05.22
28.05.22
-
28.05.23
28.05.23
-56.27%
24.04.23
24.04.23
Probably not worthwhile Investment
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€36.73
11.03.23
11.03.23
€30.00
11.03.24
11.03.24
0.48%
18.04.23
18.04.23
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.34
12.09.22
12.09.22
-
12.09.23
12.09.23
-93.70%
02.04.23
02.04.23
Could be very worthwhile Investment >20% year
Excellon Resources Inc
Start price
Target price
Perf. (%)
€0.77
27.03.22
27.03.22
-
27.03.23
27.03.23
-64.08%
27.03.23
27.03.23
Risky Investment